Literature DB >> 19340866

Impact of treating facilities' volume on survival for early-stage laryngeal cancer.

Amy Y Chen1, Alex Pavluck, Michael Halpern, Elizabeth Ward.   

Abstract

BACKGROUND: Treatment at a high-volume facility has been associated with better outcomes in a variety of conditions. The relationship between volume and survival from laryngeal cancer has not been examined previously.
METHODS: A total of 11,446 early-stage laryngeal cancer patients (1996-1998) who reported to the National Cancer Database (NCDB) were analyzed. Proportional hazards regression was used to assess the relationship between survival and treatment volume controlling for other factors associated with survival.
RESULTS: Treatment at low-volume facilities was associated with a significantly increased likelihood of death (hazard ratio 1.20, 95% CI 1.04-1.38). Surgical resection, as compared with radiation treatment, was associated with lower mortality (HR 0.74, 95% CI 0.69-0.80).
CONCLUSION: This study is the first to assess the relationship between survival and treatment volume in laryngeal cancer. Treatment at a high-volume facility is associated with better survival. Surgical treatment rather than radiation was also associated with better survival, although we could not control for confounders that may bias treatment selection.

Entities:  

Mesh:

Year:  2009        PMID: 19340866     DOI: 10.1002/hed.21072

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  22 in total

Review 1.  Quality of care in head and neck cancer.

Authors:  Carol M Lewis; Randal S Weber; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

Review 2.  Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.

Authors:  Matthew T Greulich; Noah P Parker; Philip Lee; Albert L Merati; Stephanie Misono
Journal:  Otolaryngol Head Neck Surg       Date:  2015-04-02       Impact factor: 3.497

Review 3.  Defining value-driven care in head and neck oncology.

Authors:  Benjamin R Roman; Mahmoud I Awad; Snehal G Patel
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

4.  Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis.

Authors:  Stephanie Misono; Schelomo Marmor; Bevan Yueh; Beth A Virnig
Journal:  Cancer       Date:  2014-03-17       Impact factor: 6.860

5.  Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.

Authors:  Matthew Koshy; David J Sher; Michael Spiotto; Zain Husain; Herb Engelhard; Konstantin Slavin; Martin K Nicholas; Ralph R Weichselbaum; Chad Rusthoven
Journal:  J Neurooncol       Date:  2017-08-23       Impact factor: 4.130

6.  Quality initiatives in head and neck cancer.

Authors:  Amy Y Chen
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

7.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

8.  Association of Hospital Volume With Laryngectomy Outcomes in Patients With Larynx Cancer.

Authors:  Christine G Gourin; C Matthew Stewart; Kevin D Frick; Carole Fakhry; Karen T Pitman; David W Eisele; J Matthew Austin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-01-01       Impact factor: 6.223

9.  Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.

Authors:  Arun Sharma; Stephen M Schwartz; Eduardo Méndez
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

Review 10.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.